Hypercholerolemia
6
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (6)
Bioequivalence Study of AJU-C715 and C715R in Healthy Adult Volunteers
Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome
Effects of Statins and Hormone Replacement Therapy in Coagulation Profile of Menopausal Women With Dyslipidemia
Faisalabad Initiative of Research and Management of NCDs
Study of the Effects of Yerba Mate on Cardiometabolic Health
A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)